Metabolomics Takes Another Step Forward as Methodology for Clinical Laboratory Testing with Development of an Assay for the Diagnosis of Concussion
A new blood test for concussion demonstrates how multiple metabolomic biomarkers have the potential to be used by medical laboratories for diagnostic testing purposes
Medical laboratories and pathology groups will soon see new blood tests that measure hundreds of biomarkers. One such test is being developed by Children’s Health Research Institute, a Lawson Health Research Institute program, and Western University in Ontario, Canada. This test, based on metabolomics, has been shown to be 90% accurate for diagnosing concussion in preliminary studies.
In an article published on Brainline.org, an organization dedicated to the prevention and treatment of traumatic brain injuries (TBIs), Melissa Duff, PhD, Assistant Professor in the Department of Communication Sciences and Disorders and the Department of Neurology at the University of Iowa, wrote, “The risk of concussion is highest in the 15- to 19-year-old age group. In addition, males are at higher risk than females.” Thus, the Lawson team focused on developing a test for the group that is most at-risk for concussion—adolescent males. (more…)
